Targeting adenosine in SSc
Sign Up to like & getrecommendations! Published in 2020 at "Nature Reviews Rheumatology"
DOI: 10.1038/s41584-020-0435-z
Abstract: Aberrant activation of adenosinedependent signalling has been implicated in a number of fibrotic diseases, including systemic sclerosis (SSc). The results of a new study indicate that adenosine depletion with recombinant pegylated adenosine deaminase (PEG-ADA) improves… read more here.
Keywords: ssc; ada; treatment; fra2 transgenic ... See more keywords